Aprepitant
- Strength
- 125 mg/1
- Form
- Capsule
- Class
- Substance P/Neurokinin-1 Receptor Antag…
Sandoz Inc
Not stocked by us — reference only
APREPITANT
Listed by Heron Therapeutics, Inc.
| Dosage form | Emulsion |
|---|---|
| Route | Intravenous |
| Drug class | Substance P/Neurokinin-1 Receptor Antagonist |
| Approval route | NDA — original brand approval |
| NDC code | 47426-401 |
| FDA application | NDA216457 |
| RxNorm concept | 2631783 |
| Package sizes listed | 1 |
| Marketed since | March 2023 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Sandoz Inc
Not stocked by us — reference only
Sandoz Inc
Not stocked by us — reference only
Golden State Medical Supply, Inc.
Not stocked by us — reference only
Glenmark Pharmaceuticals Inc., USA
Not stocked by us — reference only
Sandoz Inc
Not stocked by us — reference only
Golden State Medical Supply, Inc.
Not stocked by us — reference only
Torrent Pharmaceuticals Limited
Not stocked by us — reference only
BluePoint Laboratories
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.